Insider Stock Trading History of Belbel Caesar J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Belbel Caesar J since year 2005. The trader's CIK number is 1109753. At the time of this reporting, Belbel Caesar J is the COO, CLO, and Secretary of Ziopharm Oncology Inc . (stock ticker symbol ZIOP). See this page for all insider trading activities at Ziopharm Oncology Inc .

Note that in the past BELBEL CAESAR J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Belbel Caesar J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-11-19 ZIOP Ziopharm Oncology Inc Option Ex 153,333 2.30 352,665
2015-11-19 ZIOP Ziopharm Oncology Inc Sale 153,333 12.84 1,968,795
2007-12-14 CLDA Clinical Data Inc Option Ex 2,000 3.21 6,420
2007-12-14 CLDA Clinical Data Inc Sale 2,000 22.08 44,150
2007-12-11 CLDA Clinical Data Inc Option Ex 3,950 3.21 12,679
2007-12-12 CLDA Clinical Data Inc Option Ex 4,241 3.21 13,613
2007-12-11 CLDA Clinical Data Inc Sale 3,950 22.20 87,693
2007-12-12 CLDA Clinical Data Inc Sale 4,241 23.15 98,179
2006-02-27 CLDA Clinical Data Inc Option Ex 3,094 4.82 14,913
2006-02-28 CLDA Clinical Data Inc Option Ex 1,506 4.82 7,258
2006-02-27 CLDA Clinical Data Inc Sale 3,094 23.16 71,657
2006-02-28 CLDA Clinical Data Inc Sale 1,506 22.80 34,339
2006-02-23 CLDA Clinical Data Inc Option Ex 2,000 4.82 9,640
2006-02-24 CLDA Clinical Data Inc Option Ex 900 4.82 4,338
2006-02-23 CLDA Clinical Data Inc Sale 2,900 23.41 67,897

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Belbel Caesar J (COO, CLO, and Secretary of Ziopharm Oncology Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.